Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ARG1 | P05089 | 1/20 | 0.53 |
| ▸ | ARG2 | P78540 | 1/20 | 0.53 |
| ▸ | ACLY | P53396 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.47 |
| ▸ | GGT1 | P19440 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.35 |
| ▸ | CPT2 | P23786 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | ACACB | O00763 | 1/20 | 0.34 |
| ▸ | ACACA | Q13085 | 1/20 | 0.34 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.34 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.34 |
| ▸ | USP2 | O75604 | 3/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.34 |
| ▸ | RECQL | P46063 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22862319 | 1.00 | ARG1 (0.53) | ARG1ARG2ACLYMAPTABCC4 | |
| SCHEMBL1976899 | 1.00 | ARG1 (0.53) | ARG1ARG2ACLYMAPTABCC4 | |
| SCHEMBL19305278 | 1.00 | ARG1 (0.53) | ARG1ARG2ACLYMAPTABCC4 | |
| SCHEMBL19357334 | 1.00 | ARG1 (0.53) | ARG1ARG2ACLYMAPTABCC4 | |
| SCHEMBL1975910 | 1.00 | ARG1 (0.53) | ARG1ARG2ACLYMAPTABCC4 | |
| SCHEMBL18954854 | 1.00 | ARG1 (0.53) | ARG1ARG2ACLYMAPTABCC4 | |
| SCHEMBL18954850 | 1.00 | ARG1 (0.53) | ARG1ARG2ACLYMAPTABCC4 | |
| SCHEMBL16401653 | 0.98 | ARG1 (0.55) | ARG1ARG2ACLYMAPTABCC4 | |
| SCHEMBL18954910 | 0.98 | ARG1 (0.55) | ARG1ARG2ACLYMAPTABCC4 | |
| SCHEMBL19305277 | 0.98 | ARG1 (0.55) | ARG1ARG2ACLYMAPTABCC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 210 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4720088-A1 | CONSTRAINED PEPTIDE INHIBITORS OF LRRK2-FADD INTERACTIONS | University of Georgia Research Foundation, Inc. (US) | 2026-04-08 | — | — | EP | claimed |
| EP-4713348-A1 | DOUBLY CONSTRAINED PEPTIDES AS ALLOSTERIC INHIBITORS OF LEUCINE RICH REPEAT KINASE 2 | University of Georgia Research Foundation, Inc. (US) | 2026-03-25 | — | — | EP | claimed |
| US-12391733-B2 | Stapled intracellular-targeting antimicrobial peptides to treat infection | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2025-08-19 | — | — | US | claimed |
| WO-2025085624-A1 | INHIBITORS OF RAB-RILPL INTERACTIONS AND USES THEREOF | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2025-04-24 | — | — | WO | claimed |
| US-12264185-B2 | Stabilized BCL9 peptides for treatment of aberrant Wnt signaling | WNTRX PHARMACEUTICALS INC. (US) | 2025-04-01 | — | — | US | claimed |
| US-20250042961-A1 | P53 PEPTIDOMIMETIC MACROCYCLES | AGENCY FOR SCIENCE TECHNOLOGY AND RESEARCH (SG) | 2025-02-06 | — | — | US | claimed |
| WO-2024243509-A1 | CONSTRAINED PEPTIDE INHIBITORS OF LRRK2-FADD INTERACTIONS | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2024-11-28 | — | — | WO | claimed |
| EP-4467153-A1 | CONSTRAINED PEPTIDE INHIBITORS OF LRRK2-FADD INTERACTIONS | University of Georgia Research Foundation, Inc. (US) | 2024-11-27 | — | — | EP | claimed |
| WO-2024238623-A1 | DOUBLY CONSTRAINED PEPTIDES AS ALLOSTERIC INHIBITORS OF LEUCINE RICH REPEAT KINASE 2 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2024-11-21 | — | — | WO | claimed |
| CN-118829648-A | P53 peptidomimetic macrocycles | 默沙东有限责任公司 | 2024-10-22 | — | — | CN | claimed |
| US-10308684-B2 | Cell penetrating stapled peptide, manufacturing method therefor, and use thereof | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) | 2019-06-04 | — | — | US | claimed |
| US-20190023754-A1 | Stabilized BCL9 Peptides for Treatment of Aberrant WNT Signaling | WNTRX PHARMACEUTICALS INC. | 2019-01-24 | — | — | US | claimed |
| US-20170342108-A1 | CELL PENETRATING STAPLED PEPTIDE, MANUFACTURING METHOD THEREFOR, AND USE THEREOF | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) | 2017-11-30 | — | — | US | claimed |
| WO-2017062518-A1 | STABILIZED BCL9 PEPTIDES FOR TREATMENT OF ABERRANT WNT SIGNALING | WNTRX PHARMACEUTICALS INC. (US) | 2017-04-13 | — | — | WO | claimed |
| US-9447156-B2 | Methods and compositions for inhibiting neddylation of proteins | ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) | 2016-09-20 | — | — | US | claimed |
| US-20160046672-A1 | STAPLING eIF4E INTERACTING PEPTIDES | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2016-02-18 | — | — | US | claimed |
| EP-2976354-A1 | STAPLING eIF4E INTERACTING PEPTIDES | Agency For Science, Technology And Research (SG) | 2016-01-27 | — | — | EP | claimed |
| WO-2014149001-A1 | STAPLING eIF4E INTERACTING PEPTIDES | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2014-09-25 | — | — | WO | claimed |
| US-20140179593-A1 | METHODS AND COMPOSITIONS FOR INHIBITING NEDDYLATION OF PROTEINS | ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) | 2014-06-26 | — | — | US | claimed |
| WO-2012158789-A2 | METHODS AND COMPOSITIONS FOR INHIBITING NEDDYLATION OF PROTEINS | ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) | 2012-11-22 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140179593-A1 | METHODS AND COMPOSITIONS FOR INHIBITING NEDDYLATION OF PROTEINS | NEDD8, UBE3C, UBE2M | ARG1 3783/4885ARG2 4280/4885ACLY 3438/4885 |
| US-20160046672-A1 | STAPLING eIF4E INTERACTING PEPTIDES | EIF4EBP1, EIF4E, EIF4G2 | ARG1 3514/4885ARG2 3182/4885ACLY 3448/4885 |
| US-12391733-B2 | Stapled intracellular-targeting antimicrobial peptides to treat infection | VIP, SPPL2B, HM13 | ARG1 329/4885ARG2 293/4885ACLY 3331/4885 |
| US-20250042961-A1 | P53 PEPTIDOMIMETIC MACROCYCLES | TP53, MDM2, MDM4 | ARG1 821/4885ARG2 694/4885ACLY 1378/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.